Short Bowel Syndrome: Clinical Trials

26 trials for Short Bowel Syndrome, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

10 completed, 5 terminated, 4 withdrawn, 3 recruiting. 26 Phase 2, 5 Phase 1, 3 Phase 3.

By phase and status

PhaseTrialsStatus
Phase 226Completed 10, Terminated 5, Withdrawn 4, Recruiting 3, Unknown 3, Not yet recruiting 1
Phase 15Completed 2, Terminated 1, Unknown 1, Withdrawn 1
Phase 33Completed 2, Terminated 1

Follow Short Bowel Syndrome: new trials by email Literature Review of Short Bowel Syndrome trials Research Report on Short Bowel Syndrome

Trials (filtered) newest first · largest first

All 26 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Efficacy and Safety of TRA16 Administered Orally in Patients With Enteric Hyperoxaluria (EH).
TRA16, Placebo - Enteric Hyperoxaluria
Phase 2Not yet recruitingWuhan Kangfude Urolithiasis Research Institute Co., Ltd.302027-03-012026-10-13
A Clinical Study of FT1 in Patients With Short Bowel Syndrome
FT1, Placebo - Short Bowel Syndrome, SBS
Phase 2RecruitingChongqing Peg-Bio Biopharm Co., Ltd.82026-08-302026-07-15
Safety and Efficacy of Crofelemer in Adult Patients With Short Bowel Syndrome and Intestinal Failure (SBS-IF) Without Colon-in-continuity (CIC)
Crofelemer Powder for Oral Solution, Matched Placebo Powder for Oral Solution - Short Bowel Syndrome, Malabsorption Syndromes
Phase 2RecruitingNapo Therapeutics, S.p.A.182025-05-292026-06-09
Phase 2 Study to Assess the Safety, PK, and PD of Sonefpeglutide (HM15912) in SBS-IF Subjects
HM15912 Active, Placebo - Short Bowel Syndrome
Phase 2RecruitingHanmi Pharmaceutical Company Limited182022-03-032026-08-12
Functional Sucrase Deficiency in Short Bowel Syndrome Patients With Intestinal Failure
Sucrase, Placebo - Short Gut Syndrome
Phase 2TerminatedUniversity of Miami32022-01-312025-10-01
Metabolic Balance Study of Apraglutide in Patients With Short Bowel Syndrome, Intestinal Failure (SBS-IF) and Colon-in-Continuity (CIC)
Apraglutide - Short Bowel Syndrome
Phase 2CompletedVectivBio AG102021-06-142025-06-18
VIBRANT Study of Vurolenatide in Adult Patients With Short Bowel Syndrome.
Vurolenatide 50mg/PBO, Vurolenatide 100mg/PBO, Vurolenatide 50/50 mg - Short Bowel Syndrome
Phase 2Terminated9 Meters Biopharma, Inc.122021-06-142022-12-20
Use of Tocofersolan (VedropĀ®) to Prevent or Treat Refractive Vitamin E Deficiency in Infants and Children
Tocofersolan - Short Bowel Syndrome, Vitamin E Deficiency
Phase 2WithdrawnBoston Children's Hospital2020-12-012020-05-13
Proof of Concept Study in Patients With Short Bowel Syndrome
NM-002 - Short Bowel Syndrome
Phase 1 / Phase 2Unknown9 Meters Biopharma, Inc.122020-06-232020-11-20
Efficacy, Safety and Tolerability of Enteric-Coated Cholestyramine Capsules for Adult Short Bowel Syndrome
Enteric-Coated Cholestyramine (ECC) Capsule, Placebo - Short Bowel Syndrome
Phase 2TerminatedPharmascience Inc.132019-10-152022-07-19
Safety, Efficacy, PD of FE203799 in Short Bowel Syndrome on Parenteral Support
FE203799 GLP-2 analogue, FE203799 Placebo GLP-2 analogue - Short Bowel Syndrome
Phase 1 / Phase 2CompletedGlyPharma Therapeutics82018-05-082024-10-26
Metabolic Balance Study of FE203799 in Patients With SBS With Intestinal Insufficiency
FE203799 - SBS - Short Bowel Syndrome
Phase 1 / Phase 2CompletedGlyPharma Therapeutics82018-05-022024-10-24
Liraglutide on Decreasing Parenteral Support in Short Bowel Patients (SLIPS)
Liraglutide Pen Injector [Victoza] - Short Bowel Syndrome
Phase 2WithdrawnImperial College London2017-10-202020-08-14
Use of Pancreatic Enzymes in Short Bowel Syndrome
Pancreatic Enzyme - Short Bowel Syndrome
Phase 2CompletedChildren's Hospital of Philadelphia162017-03-242020-03-20
Safety and Efficacy Study in Infant With SBS
NTRA-9620, Placebo - Short Bowel Syndrome
Phase 2 / Phase 3TerminatedElgan Pharma Ltd.22017-03-202021-10-12
A Phase 2 Trial Testing ZP1848 in Patients With SBS
ZP1848 - Short Bowel Syndrome
Phase 2CompletedZealand Pharma182016-02-012017-06-21
Compassionate Use of Omegaven in Children
Omegaven - Total Parenteral Nutrition-induced Cholestasis, Cholestasis
Phase 2 / Phase 3CompletedUniversity of Oklahoma632015-06-012019-11-25
Early Supplementation of Enteral Microlipid With and Without Fish Oil in Premature Infants With Enterostomies
Microlipid with fish oil, Microlipid - Prematurity, Intestine Perforation
Phase 2CompletedWake Forest University182012-10-012018-12-04
Safety and Dosing Study of Glucagon-like Peptide 2 (GLP-2) in Infants and Children With Intestinal Failure
Glucagon-Like Peptide 2, Glucagon like peptide-2 - Intestinal Failure, Short Bowel Syndrome
Phase 1 / Phase 2TerminatedAlberta Children's Hospital132012-01-012014-12-23
Trial of 70% Ethanol Versus Heparin to Reduce the Rate of Central Line Infections in Children With Short Bowel Syndrome
70% ethanol - Catheter Related Infections, Short Bowel Syndrome
Phase 2WithdrawnBoston Children's Hospital2011-02-012017-06-22

Showing 20 of 26. Sign in to see all of them.

Narrower conditions

Cholestasis (4)  ·  Intestinal Failure (4)  ·  Enterocolitis, Necrotizing (2)  ·  Gastrointestinal Diseases (2)  ·  Gastroschisis (2)  ·  Intestinal Atresia (2)  ·  Catheter-Related Infections (1)  ·  Colitis, Ulcerative (1)  ·  Crohn Disease (1)  ·  Hyperphagia (1)  ·  Infant Nutrition Disorders (1)  ·  Infant, Premature, Diseases (1)  ·  Intestinal Perforation (1)  ·  Kidney Calculi (1)

Broader conditions

Digestive System Diseases (26)  ·  Intestinal Diseases (26)  ·  Pathologic Processes (26)  ·  Pathological Conditions, Signs and Symptoms (26)  ·  Malabsorption Syndromes (25)  ·  Postoperative Complications (25)  ·  Gastrointestinal Diseases (24)  ·  Bile Duct Diseases (4)  ·  Biliary Tract Diseases (4)  ·  Gastroenteritis (3)  ·  Nutritional and Metabolic Diseases (3)  ·  Pathological Conditions, Anatomical (3)  ·  Congenital Abnormalities (2)  ·  Congenital, Hereditary, and Neonatal Diseases and Abnormalities (2)  ·  Digestive System Abnormalities (2)

Interventions

fish oil triglycerides (3)  ·  Fish Oils (2)  ·  Capsules (1)  ·  Corn Oil (1)  ·  Diet Therapy (1)  ·  Ethanol (1)  ·  Glucagon-Like Peptide 2 (1)  ·  Growth Hormone (1)  ·  Liraglutide (1)  ·  Omacor (1)  ·  Pancrelipase (1)  ·  Safflower Oil (1)  ·  Solutions (1)  ·  Sucrase (1)  ·  apraglutide (1)

Sponsors

Boston Children's Hospital (3)  ·  9 Meters Biopharma, Inc. (2)  ·  GlyPharma Therapeutics (2)  ·  Alberta Children's Hospital (1)  ·  Amarnath, Rathna, M.D. (1)  ·  Children's Hospital of Philadelphia (1)  ·  Chongqing Peg-Bio Biopharm Co., Ltd. (1)  ·  Elgan Pharma Ltd. (1)  ·  Emory University (1)  ·  Hanmi Pharmaceutical Company Limited (1)  ·  Imperial College London (1)  ·  Mark Puder (1)  ·  Napo Therapeutics, S.p.A. (1)  ·  Pharmascience Inc. (1)  ·  The Hospital for Sick Children (1)

Countries

United States (14)  ·  Denmark (4)  ·  Belgium (2)  ·  Canada (2)  ·  France (2)  ·  Germany (2)  ·  Poland (2)  ·  United Kingdom (2)  ·  China (1)  ·  Italy (1)  ·  South Korea (1)

Top investigators

Tomasz Masior (3)  ·  Amanda Fifi, MD (1)  ·  Christopher Duggan, M.D, MPH (1)  ·  David Sigalet, MD PhD (1)  ·  Gertrud Koefoed Rasmussen, MSc (1)  ·  Kimberly D Ernst, MD, MSMI (1)  ·  Kinga Szczepanek, MD (1)  ·  Konrad Matysiak, MD, PhD (1)  ·  Marek Kunecki, MD, PhD (1)  ·  Natalie Terry, MD, PhD (1)  ·  Paul Wales (1)  ·  Qing Yang, MD, PhD (1)  ·  Ricardo A. Caicedo, MD (1)  ·  Siddhartha Oke (1)  ·  Terra R Varner, PharmD (1)

Results publications

PMID 19661785, PMID 20980771, PMID 21324480, PMID 23453547, PMID 26838529, PMID 30880176, PMID 31326433, PMID 32059815, PMID 33038344, PMID 34287970, PMID 34287979, PMID 34695449, PMID 35622082, PMID 39461299, PMID 41903849

NIH funding

2018 (1), R01DK055850 (1)